Search

Your search keyword '"Wu, Xiaolin"' showing total 35 results

Search Constraints

Start Over You searched for: Author "Wu, Xiaolin" Remove constraint Author: "Wu, Xiaolin" Publisher american association for cancer research (aacr) Remove constraint Publisher: american association for cancer research (aacr)
35 results on '"Wu, Xiaolin"'

Search Results

1. Abstract A006: Reckless mitotic entry as a novel chemosensitization approach for alkylating agents

2. Data from Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases

3. Supplementary Data 1 from Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases

4. Figure S1 from Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases

5. Supplementary Data from Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM+ Hepatocellular Carcinoma

6. Supplementary Table S1 from Accelerated Preclinical Testing Using Transplanted Tumors from Genetically Engineered Mouse Breast Cancer Models

7. Data from Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM+ Hepatocellular Carcinoma

8. Supplementary Data from The NCI Transcriptional Pharmacodynamics Workbench: A Tool to Examine Dynamic Expression Profiling of Therapeutic Response in the NCI-60 Cell Line Panel

9. Supplementary Figure Legend from Accelerated Preclinical Testing Using Transplanted Tumors from Genetically Engineered Mouse Breast Cancer Models

11. Data from The NCI Transcriptional Pharmacodynamics Workbench: A Tool to Examine Dynamic Expression Profiling of Therapeutic Response in the NCI-60 Cell Line Panel

12. Supplementary Figures S1-S4 from Accelerated Preclinical Testing Using Transplanted Tumors from Genetically Engineered Mouse Breast Cancer Models

21. Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases

23. Abstract 4611: A multicenter clinical study of stool DNA test of methylated syndecan-2 for colorectal cancer detection

25. Abstract 4611: A multicenter clinical study of stool DNA test of methylated syndecan-2 for colorectal cancer detection

26. Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM+ Hepatocellular Carcinoma

27. The NCI Transcriptional Pharmacodynamics Workbench: A Tool to Examine Dynamic Expression Profiling of Therapeutic Response in the NCI-60 Cell Line Panel

28. Abstract 4873: IKKα bridges central tolerance to innate immunity and inflammation

30. Abstract 1083: The pivotal role of IKKalpha in the development of spontaneous lung squamous cell carcinomas.

32. Relationship ofEGFRMutations, Expression, Amplification, and Polymorphisms to Epidermal Growth Factor Receptor Inhibitors in the NCI60 Cell Lines

34. Accelerated Preclinical Testing Using Transplanted Tumors from Genetically Engineered Mouse Breast Cancer Models

Catalog

Books, media, physical & digital resources